How are you managing care delivery during the COVID-19 pandemic?

FAQ Library published on May 20, 2020
Download Transcript Download Audio
Sagar Lonial, MD, FACP
Chair and Professor
Department of Hematology and Medical Oncology
Chief Medical Officer
Winship Cancer Institute
Emory University School of Medicine
Atlanta, Georgia

Welcome to Managing Myeloma, I have recently been asked, “How are you managing care delivery during the COVID-19 pandemic?” I think that there are a number of different ways to potentially evaluate this question. The most important is, are the treatments that you are using, the benefit of those treatments greater than the potential risk of developing or being exposed to COVID-19 either through coming to the infusion center or coming to see us in the clinic? So we have done a number of things to reduce the traffic through our building to reduce the risk of exposure, universal masking both by patients and staff is one approach that we have taken, and finally, starting to think through, can we reduce dexamethasone? Can we reduce the frequency of IV infusions and switch to predominantly oral treatment approaches during this time to minimize the risks of patients during the COVID-19 pandemic?

Last modified: May 19, 2020